- Letter to the Editor: Cardiac arrest caused by nafamostat mesilate: Kounis syndrome in the dialysis room?
-
Koniari I, Kounis NG
- KMID: 2409396
- Kidney Res Clin Pract.
- 2017 Mar;36(1):105-106.
- doi: 10.23876/j.krcp.2017.36.1.105
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The authors' reply: Letter to the Editor: Cardiac arrest caused by nafamostat mesilate: Kounis syndrome in the dialysis room?
-
Kim HS, Noh H
- KMID: 2409397
- Kidney Res Clin Pract.
- 2017 Mar;36(1):107-107.
- doi: 10.23876/j.krcp.2017.36.1.107
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Plantar Keratoderma with Pachyonychia Likely Induced by Imatinib Mesylate
-
Kim HO, Lee BI, Lee JY, Park YM
- KMID: 2265085
- Ann Dermatol.
- 2013 Nov;25(4):526-528.
- doi: 10.5021/ad.2013.25.4.526
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Lichenoid Drug Eruption after Low-Dose Imatinib Mesylate Treatment
-
Lee JH, Chung JY, Jung MY, Kim CR, Park JH, Park JH, Lee JH, Lee JH, Yang JM, Lee DY
- KMID: 2265073
- Ann Dermatol.
- 2013 Nov;25(4):500-502.
- doi: 10.5021/ad.2013.25.4.500
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Reversal of Marrow Fibrosis Following Imatinib Mesylate Therapy in a Patient with Chronic Myelogenous Leukemia Who Was Refractory to Interferon-alpha
-
Kim YS, Kim TH, Kim WC, Jeon YJ, Kil UH, Lee HK, Kim YS, Rho SY, Cho SG
- KMID: 2252349
- Korean J Hematol.
- 2005 Jun;40(2):124-128.
- doi: 10.5045/kjh.2005.40.2.124
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec(TM))
-
Cho AY, Kim DH, Im M, Lee Y, Seo YJ, Lee JH
- KMID: 2171872
- Ann Dermatol.
- 2011 Dec;23(Suppl 3):S360-S363.
- doi: 10.5021/ad.2011.23.S3.S360
Imatinib mesylate (Gleevec(TM), STI571), a selective inhibitor of BCR-ABL, c-Kit, and platelet-derived factor receptor, has been used to treat chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors. Although its use... -
- CITED
-
- Close
- SHARE
-
- Close
- Amyotrophic Lateral Sclerosis with an Acute Hypertensive Crises
-
Lee HL, Lee JK
- KMID: 2266751
- Ann Rehabil Med.
- 2012 Jun;36(3):418-422.
- doi: 10.5535/arm.2012.36.3.418
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder involving the systemic motor neurons, but autonomic nervous function is relatively well preserved. A few studies related to autonomic dysfunction have... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Psoriasiform Drug Eruption Induced by Imatinib Mesylate (GleevecTM)
-
Bae YI, Yun SJ, Lee JB, Kim SJ, Lee SC, Won YH
- KMID: 2247824
- Korean J Dermatol.
- 2009 Jun;47(6):722-725.
Imatinib mesylate (GleevecTM, formerly known as STI571) is an oral drug that selectively inhibits bcr-abl, c-kit and platelet-derived factor receptor (PDGFR) tyrosine kinase. It has been used for treating chronic... -
- CITED
-
- Close
- SHARE
-
- Close
- Biphasic anaphylaxis to gemifloxacin
-
Yilmaz I, Doğan S, Tutar N, Kanbay A, Büyükoğlan H, Demir R
- KMID: 2397446
- Asia Pac Allergy.
- 2012 Oct;2(4):280-282.
- doi: 10.5415/apallergy.2012.2.4.280
Anaphylaxis have been documented as adverse effects of ciprofloxacin, ofloxacin, norfloxacin, levofloxacin, and moxifloxacin. However resistant and biphasic anaphlylactic reactions to gemifloxacin have not been reported to date. Management of... -
- CITED
-
- Close
- SHARE
-
- Close
- Data exclusivity through New Drug Reexamination in Korea: sibutramine hydrochloride (Reductil®) vs. sibutramine mesylate (Slimmer®) as an example
-
Lee H
- KMID: 2413826
- Transl Clin Pharmacol.
- 2018 Jun;26(2):49-55.
- doi: 10.12793/tcp.2018.26.2.49
The ‘equivalent-or-more-but-not-the-same-data’ provision in the Regulation on the Safety and Efficacy Evaluation of New Drug in Korea has served as the de facto data exclusivity term for any drug identical... -
- CITED
-
- Close
- SHARE
-
- Close
- Complete remission of philadelphia chromosome-positive acute myeloid leukemia with imatinib mesylate
-
Jang SB, Bae SH, Jung HR, Yoon SY, Jun EJ, Kang GW, Ryoo HM
- KMID: 2259216
- Korean J Med.
- 2010 Jan;78(1):132-137.
Philadelphia chromosome-positive acute myeloid leukemia (Ph+AML) is a rare disease characterized by a poor prognosis with resistance to standard chemotherapy. We report a patient with Ph+AML with a minor BCR-ABL-positive... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Drug Eruption with Localized ExfoliativeDermatitis Induced by Imatinib Mesylate
-
Yoo KH, Rho YK, Kim JY, Li K, Seo SJ, Hong CK
- KMID: 2248087
- Korean J Dermatol.
- 2008 Oct;46(10):1435-1438.
Imatinib mesylate (Gleevec(R), formerly known as STI571) is a protein-tyrosine kinase inhibitor that inhibits the bcr-abl tyrosine kinase created by the Philadelphia chromosome abnormality in patients with chronic myeloid leukemia... -
- CITED
-
- Close
- SHARE
-
- Close
- Generation and Evaluation of High beta-Glucan Producing Mutant Strains of Sparassis crispa
-
Kim SR, Kang HW, Ro HS
- KMID: 1964231
- Mycobiology.
- 2013 Sep;41(3):159-163.
- doi: 10.5941/MYCO.2013.41.3.159
A chemical mutagenesis technique was employed for development of mutant strains of Sparassis crispa targeting the shortened cultivation time and the high beta-glucan content. The homogenized mycelial fragments of S.... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Drug Eruption with Periorbital Edema and Exfoliative Dermatitis Induced by Imatinib Mesylate (STI571, Gleevec(TM))
-
Joo YH, Min SU, Lee DH, Suh DH
- KMID: 2302247
- Korean J Dermatol.
- 2007 Feb;45(2):194-196.
STI571 (imatinib mesylate, Gleevec(TM)), a selective inhibitor of the bcr-abl, c-kit, platelet-derived growth factor receptor tyrosine kinases, is a new anticancer drug used for chronic myelogenous leukemia and gastrointestinal stromal... -
- CITED
-
- Close
- SHARE
-
- Close
- Imatinib-induced Psoriasiform Drug Eruption in a Patient with a Gastrointestinal Stromal Tumor
-
Lee YJ, Lee WJ, Chang S, Lee MW, Choi JH, Moon KC
- KMID: 2246088
- Korean J Dermatol.
- 2015 Jun;53(5):388-391.
Imatinib mesylate (Gleevec(R)) is a small-molecule inhibitor that selectively inhibits the tyrosine kinase family, including mutated KIT oncoproteins in gastrointestinal stromal tumors (GIST). However, cutaneous reactions to imatinib are common... -
- CITED
-
- Close
- SHARE
-
- Close
- Imatinib Mesylate (Gleevec(TM))-induced Lichenoid Drug Eruption Improved by Tentative Dose-reduction and Topical Steroid
-
Yang JH, Shin JW, Kim HD, Park YL, Lee SY, Whang KU
- KMID: 2303581
- Korean J Dermatol.
- 2011 Feb;49(2):155-158.
Imatinib mesylate (Gleevec(TM)) is an oral anticancer drug. It works as a selective and competitive inhibitor of tyrosine kinases such as bcr-abl protein, c-kit, and platelet-derived growth factor receptors (PDGFR).... -
- CITED
-
- Close
- SHARE
-
- Close
- Two Cases of Heparin-Induced Thrombocytopenia in Hemodialysis Patients
-
Choi HJ, Lee DH, Youn YD, Kim SH, Rhee JA, Chang SH, Suh JS
- KMID: 2079590
- Korean J Nephrol.
- 2006 Jan;25(1):135-140.
Heparin, a widely used anticoagulant, is currently the anticoagulant of choice in long-term hemodialysis (HD). Heparin-induced thrombocytopenia (HIT) is one of the most serious side effects of heparin which can... -
- CITED
-
- Close
- SHARE
-
- Close
- Imatinib Mesylate Induced Acquired Dermal Melanocytosis
-
Kim EK, Jung KE, Kim HS, Park YM, Kim HO, Lee JY
- KMID: 2301602
- Korean J Dermatol.
- 2012 Aug;50(8):747-750.
Dermal melanocytosis is most commonly found in the skin of Asians and other darkly pigmented populations. It is histologically characterized by the presence of ectopic melanocytes in the dermis. Mongolian... -
- CITED
-
- Close
- SHARE
-
- Close
- Imatinib-Mesylate Induced Interstitial Pneumonitis in Two CML Patients
-
Kim TH, Kim BG, Cho SW, Cho SK, Kim HJ, Yuh YJ, Kim SR
- KMID: 2319555
- Tuberc Respir Dis.
- 2011 Sep;71(3):210-215.
Imatinib mesylate, a selective inhibitor of BCR-ABL kinase activity, has demonstrated significant clinical efficacy in the treatment of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). It has become... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Imatinib Mesylate Treatment for a Patient with Rheumatoid Arthritis and Who Developed Chronic Myelogenous Leukemia
-
Jeon HK, Park YE, Kim SI, Park SH, Baek SH, Lee JW, Ha DW, Lee HW, Chung JS, Lee SH, Lee EY
- KMID: 2391939
- J Rheum Dis.
- 2011 Jun;18(2):118-121.
Rheumatoid arthritis is associated with an increased risk of hematological malignancy as a result of the RA itself or its treatment. We report here on an unusual case of a... -
- CITED
-
- Close
- SHARE
-
- Close
